Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · IEX Real-Time Price · USD
5.71
-0.29 (-4.83%)
At close: Jun 17, 2024, 4:00 PM
5.53
-0.18 (-3.15%)
After-hours: Jun 17, 2024, 4:06 PM EDT
Syros Pharmaceuticals Market Cap
Syros Pharmaceuticals has a market cap or net worth of $152.62 million as of June 17, 2024. Its market cap has increased by 112.27% in one year.
Market Cap
152.62M
Enterprise Value
103.87M
1-Year Change
112.27%
Ranking
Category
Stock Price
$5.71
Market Cap Chart
Since June 30, 2016, Syros Pharmaceuticals's market cap has decreased from $413.10M to $152.62M, a decrease of -63.06%. That is a compound annual growth rate of -11.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 14, 2024 | 160.40M | 3.48% |
Jun 13, 2024 | 155.00M | 7.42% |
Jun 12, 2024 | 144.30M | 2.85% |
Jun 11, 2024 | 140.30M | 2.56% |
Jun 10, 2024 | 136.80M | -0.65% |
Jun 7, 2024 | 137.70M | -2.82% |
Jun 6, 2024 | 141.70M | - |
Jun 5, 2024 | 141.70M | 0.78% |
Jun 4, 2024 | 140.60M | 2.55% |
Jun 3, 2024 | 137.10M | 0.59% |
May 31, 2024 | 136.30M | 2.02% |
May 30, 2024 | 133.60M | -1.04% |
May 29, 2024 | 135.00M | 1.05% |
May 28, 2024 | 133.60M | 0.60% |
May 24, 2024 | 132.80M | -3.56% |
May 23, 2024 | 137.70M | -3.91% |
May 22, 2024 | 143.30M | -5.10% |
May 21, 2024 | 151.00M | 0.73% |
May 20, 2024 | 149.90M | 2.88% |
May 17, 2024 | 145.70M | -0.55% |
May 16, 2024 | 146.50M | -0.54% |
May 15, 2024 | 147.30M | 1.52% |
May 14, 2024 | 145.10M | 8.36% |
May 13, 2024 | 133.90M | 1.83% |
May 10, 2024 | 131.50M | -0.75% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
INmune Bio | 164.39M |
Telomir Pharmaceuticals | 162.56M |
Capricor Therapeutics | 161.60M |
Repare Therapeutics | 161.29M |
Galectin Therapeutics | 160.34M |
Rezolute | 158.13M |
CervoMed | 157.65M |
Lifecore Biomedical | 157.01M |